Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

607 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Guaiana G, Meader N, Barbui C, Davies SJ, Furukawa TA, Imai H, Dias S, Caldwell DM, Koesters M, Tajika A, Bighelli I, Pompoli A, Cipriani A, Dawson S, Robertson L. Guaiana G, et al. Among authors: davies sj. Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3. Cochrane Database Syst Rev. 2023. PMID: 38014714 Free PMC article. Review.
Agomelatine versus other antidepressive agents for major depression.
Guaiana G, Gupta S, Chiodo D, Davies SJ, Haederle K, Koesters M. Guaiana G, et al. Among authors: davies sj. Cochrane Database Syst Rev. 2013 Dec 17;2013(12):CD008851. doi: 10.1002/14651858.CD008851.pub2. Cochrane Database Syst Rev. 2013. PMID: 24343836 Free PMC article. Review.
Benzodiazepines versus placebo for panic disorder in adults.
Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, Bighelli I, Davies SJ, Furukawa TA, Koesters M. Breilmann J, et al. Among authors: davies sj. Cochrane Database Syst Rev. 2019 Mar 28;3(3):CD010677. doi: 10.1002/14651858.CD010677.pub2. Cochrane Database Syst Rev. 2019. PMID: 30921478 Free PMC article.
The definition of treatment resistance in anxiety disorders: a Delphi method-based consensus guideline.
Domschke K, Seuling PD, Schiele MA, Bandelow B, Batelaan NM, Bokma WA, Branchi I, Broich K, Burkauskas J, Davies SJC, Dell'Osso B, Fagan H, Fineberg NA, Furukawa TA, Hofmann SG, Hood S, Huneke NTM, Latas M, Lidbetter N, Masdrakis V, McAllister-Williams RH, Nardi AE, Pallanti S, Penninx BWJH, Perna G, Pilling S, Pini S, Reif A, Seedat S, Simons G, Srivastava S, Steibliene V, Stein DJ, Stein MB, van Ameringen M, van Balkom AJLM, van der Wee N, Zwanzger P, Baldwin DS. Domschke K, et al. World Psychiatry. 2024 Feb;23(1):113-123. doi: 10.1002/wps.21177. World Psychiatry. 2024. PMID: 38214637 Free PMC article.
Symptoms of generalized anxiety disorder but not panic disorder at age 15 years increase the risk of depression at 18 years in the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort study.
Davies SJ, Pearson RM, Stapinski L, Bould H, Christmas DM, Button KS, Skapinakis P, Lewis G, Evans J. Davies SJ, et al. Psychol Med. 2016 Jan;46(1):73-85. doi: 10.1017/S003329171500149X. Epub 2015 Aug 28. Psychol Med. 2016. PMID: 26315278 Free PMC article.
Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial.
Rifkin-Zybutz R, MacNeill S, Davies SJ, Dickens C, Campbell J, Anderson IM, Chew-Graham CA, Peters TJ, Lewis G, Wiles N, Kessler D. Rifkin-Zybutz R, et al. Among authors: davies sj. J Psychopharmacol. 2020 Dec;34(12):1342-1349. doi: 10.1177/0269881120965939. Epub 2020 Nov 4. J Psychopharmacol. 2020. PMID: 33143538 Free PMC article. Clinical Trial.
607 results